drugset / Trial / NCT06699966

Stony Brook Medicine Anti-Inflammatory Trial

NCT06699966

Phase 4 Not yet recruiting 42 enrolled Stony Brook University
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an experimental study designed to measure the effect of celecoxib or minocycline on depressive symptoms in unipolar and bipolar depression. Participants will be equally randomized to either celecoxib or minocycline. All participants will complete a battery of clinical and psychological assessments prior to treatment assignment, and again after treatment completion, to assess any changes or improvements in depression.

Timeline

Start
2027-06
Primary completion
2031-06
Completion
2032-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 400 mg
Subject Minocycline Small molecule 100 mg